Journal Information
Editorials
Visceral adipose tissue: A clue to the obesity-asthma endotype(s)?
R. Barros, L. Delgado
Rev Port Pneumol. 2016;22:253-4
Open access
Original articles
Visceral adiposity is associated with cytokines and decrease in lung function in women with persistent asthma
A.V. Capelo, V.M. da Fonseca, M.V.M. Peixoto, S.R. de Carvalho, C.M. Azevedo, M.I.G. Elsas, B. Marques
Rev Port Pneumol. 2016;22:255-61
Open access
Quantitation of oxygen-induced hypercapnia in respiratory pump failure
M. Chiou, J.R. Bach, L.R. Saporito, O. Albert
Rev Port Pneumol. 2016;22:262-5
Open access
Surgical risk evaluation of lung cancer in COPD patients – A cohort observational study
F. Rodrigues, M. Grafino, I. Faria, J. Pontes da Mata, A.L. Papoila, F. Félix
Rev Port Pneumol. 2016;22:266-72
Open access
Minimally invasive repair of Morgagni hernia – A multicenter case series
R. Lamas-Pinheiro, J. Pereira, F. Carvalho, P. Horta, A. Ochoa, M. Knoblich, J. Henriques, T. Henriques-Coelho, ... J. Estevão-Costa
Rev Port Pneumol. 2016;22:273-8
Open access
Special article
Blurred lines. Eosinophilic COPD: ACOS or COPD phenotype?
C.C. Loureiro
Rev Port Pneumol. 2016;22:279-82
Open access
Clinical case
Malignant transformation of a tracheal chondroma: The second reported case and review of the literature
D. Maia, X. Elharrar, S. Laroumagne, F. Maldonado, P. Astoul, H. Dutau
Rev Port Pneumol. 2016;22:283-6
Open access
Research letters
MuTAR study, Phase II, open-label study of erlotinib (E) treatment in patients (pts) with locally advanced or metastatic non-small cell lung cancer (mNSCLC) who present activating mutations (MUT+) in the tyrosine kinase (TKI) domain of the epidermal growth factor receptor (EGFR), assessed the efficacy of 1L in Portuguese pts with mNSCLC EGFR Mut+
F. Barata, H. Queiroga, E. Teixeira, M.T. Almodovar, B. Parente, M. Soares
Rev Port Pneumol. 2016;22:287-8
Open access
Transbronchial cryobiopsy in the diagnosis of desquamative interstitial pneumonia
C. Dias, P. Mota, I. Neves, S. Guimarães, C. Souto Moura, A. Morais
Rev Port Pneumol. 2016;22:288-90
Open access
Pleural effusion cytology due to malignancy. A combined cytomorphological–immunocytochemical study of 500 cases
A. Kalogeraki, D. Tamiolakis, G. Datseri, G. Lazopoulos, M. Karvelas-Kalogerakis, J. Segredakis, I. Zoi
Rev Port Pneumol. 2016;22:290-1
Open access
High-flow oxygen therapy through nasal cannula: Prospective observational study in an intermediate care unit
P. Demelo-Rodríguez, M. Olmedo Samperio, D.G. Gaitán Tocora, J.C. Cano Ballesteros, J. del Toro Cervera, J.A. Andueza Lillo
Rev Port Pneumol. 2016;22:292-3
Open access
Asthma prevalence in Portuguese preschool children: The latest scientific evidence
P.T.B.S. Branco, R.A.O. Nunes, M.C.M. Alvim-Ferraz, F.G. Martins, C. Ferraz, L.G. Vaz, S.I.V. Sousa
Rev Port Pneumol. 2016;22:293-5
Open access
Letters to editor
A rare cause of miliary pattern and respiratory failure – Benign metastasizing leiomyoma
M. Grafino, L. Ferreira, L. Telo, S. Mira, M. Alvoeiro, C. Bárbara
Rev Port Pneumol. 2016;22:296-7
Open access
Beyond a pleural effusion: Primary pleuropulmonary sarcomas and the challenge of diagnosis
D. Apolinário, J. Silva, A.I. Loureiro, R. Noya, L. Carvalho
Rev Port Pneumol. 2016;22:298-9
Open access
Correspondence
Long term effects of nocturnal hypoxia and urinary uric acid excretion: How much linked to COPD and OSAS?
R. Gomes, H. Dabó, A.M. Esquinas
Rev Port Pneumol. 2016;22:302-3
Open access
Reply to the letter “Long term effects of nocturnal hypoxia and urinary uric acid excretion: How much linked to COPD and OSAS?”
Y. Varol, Z.Z. Ucar
Rev Port Pneumol. 2016;22:303
Open access